Bradford D. Dahms, Chief Financial Officer at Theseus Pharmaceuticals, Inc. (THRX), bought 1,502 shares at $6.66 ($10K) on 2022-11-30, disclosed to the SEC on 2022-12-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.